I78.0 ICD-10-CM Code: Hereditary hemorrhagic telangiectasia
I78.0 is not a CMS-HCC payment code. MEAT criteria · RAF calculator · free HCC coding tools
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Diseases of the circulatory system (I00-I99) / Diseases of arteries, arterioles and capillaries (I70-I79)
I78.0
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceHereditary hemorrhagic telangiectasia
Hereditary hemorrhagic telangiectasia is an inherited genetic disorder that causes abnormal blood vessels to form in the skin and internal organs, leading to frequent nosebleeds and other bleeding problems. People with this condition are born with it and may experience bleeding episodes throughout their lives.

Buddy Insight
Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease) is a genetic disorder causing abnormal blood vessel formations (arteriovenous malformations) throughout the body, leading to recurrent epistaxis, gastrointestinal bleeding, and potential organ involvement.
CMS-HCC V28
N/A—
Not mapped
CMS-HCC V24
MappedHCC 108
RAF 0.288
ACA/HHS
N/A—
Not mapped
ESRD/PACE
MappedHCC 108
RAF 0.073
RXHCC
N/A—
Not mapped
Code Book Path
Inclusion Terms
Official- Rendu-Osler-Weber disease
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for I78.0 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for I78.0 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for I78.0 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for I78.0 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for I78.0 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for I78.0 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is I78.0 an HCC code?
Yes. I78.0 maps to Vascular Disease under the V24 model but is not retained in V28.
- Code
- I78.0
- Description
- Hereditary hemorrhagic telangiectasia
- HCC (V28)
- No CMS-HCC V28 mapping
- RAF
- —
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
Each model's RAF is its CMS base weight for that model's standard population, so weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
Work I78.0 in the Code Book — tabular path, V28 RAF, and MEAT checklist →
MEAT Criteria for I78.0
For I78.0 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed I78.0 during that encounter, not just copy-forwarded from a problem list.
Coder workflow notes
Get the V28 RAF + MEAT cheat sheet
One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
I78.0 is the ICD-10-CM diagnosis code for hereditary hemorrhagic telangiectasia. Hereditary hemorrhagic telangiectasia is an inherited genetic disorder that causes abnormal blood vessels to form in the skin and internal organs, leading to frequent nosebleeds and other bleeding problems. People with this condition are born with it and may experience bleeding episodes throughout their lives. I78.0 sits in the ICD-10-CM chapter for diseases of the circulatory system (i00-i99), within the section covering diseases of arteries, arterioles and capillaries (i70-i79).
Under the older CMS-HCC V24 model, I78.0 maps to Vascular Disease (HCC 108) with a community, non-dual, aged base RAF weight of 0.288. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
This is a hereditary condition, so document family history when available to support the diagnosis and differentiate from acquired telangiectasia. Because I78.0 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for I78.0 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •This is a hereditary condition, so document family history when available to support the diagnosis and differentiate from acquired telangiectasia
- •Specify the affected site(s) if documented (e.g., pulmonary, cerebral, gastrointestinal involvement) as these may have separate codes or require additional documentation for complications
Clinical Significance
Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease) is a genetic disorder causing abnormal blood vessel formations (arteriovenous malformations) throughout the body, leading to recurrent epistaxis, gastrointestinal bleeding, and potential organ involvement. This chronic condition requires lifelong management and surveillance for pulmonary and cerebral arteriovenous malformations, reflecting ongoing resource utilization.
Documentation Requirements
- ✓Clinical diagnosis based on Curacao criteria: spontaneous recurrent epistaxis, mucocutaneous telangiectasias, visceral involvement, family history
- ✓Genetic testing results when available (endoglin, activin receptor-like kinase 1, or SMAD4 mutations)
- ✓Documentation of organ involvement including pulmonary, hepatic, or cerebral arteriovenous malformations
- ✓Iron studies and hemoglobin levels for chronic blood loss assessment
- ✓Screening schedule for pulmonary and cerebral arteriovenous malformations
- ✓Current treatment plan including iron supplementation, transfusions, or procedural interventions
Commonly Confused Codes
- •I78.1: Nevus, non-neoplastic: benign skin vascular lesion, not hereditary hemorrhagic telangiectasia
- •I78.8: Other diseases of capillaries: other capillary disorders not classified as hereditary hemorrhagic telangiectasia
- •D68.0: Von Willebrand disease: different hereditary bleeding disorder
- •R04.0: Epistaxis: symptom code only; use I78.0 for the underlying hereditary hemorrhagic telangiectasia diagnosis

